重组人粒-巨噬细胞集落刺激因子临床新应用进展

被引:8
作者
黄慧强
王潇潇
机构
[1] 中山大学肿瘤医院内科
关键词
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 [肿瘤学];
摘要
<正>重组人粒-巨噬细胞集落刺激因子(rhGM-CSF)是一种重要的多功能造血生长因子,可刺激多系造血细胞的增殖和分化,促进中性粒细胞、单核-巨噬细胞及血小板等的增殖和分化。因而被广泛应用于治疗患者放、化疗后的骨髓抑制,以及骨髓移植、再生障碍性贫血、骨髓增生异常综合征等患者相关的白细胞减少症。随着对rhGM-CSF功能研究的不断深入,其临床应用已不仅仅局限于上述领域,在肿瘤免疫治疗、抗感染及促进伤
引用
收藏
相关论文
共 8 条
[1]
Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lymphoma [J].
Karmali, Reem ;
Larson, Melissa L. ;
Wooldridge, James E. ;
Gregory, Stephanie A. ;
O'Brien, Teresa ;
Shammo, Jamile M. ;
Bueschel, Katherine ;
Venugopal, Parameswaran .
LEUKEMIA & LYMPHOMA, 2011, 52 (11) :2097-2104
[2]
Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study [J].
Chang, Julie E. ;
Seo, Songwong ;
Kim, Kyungmann M. ;
Werndli, Jae E. ;
Bottner, Wayne A. ;
Rodrigues, Gilberto A. ;
Sanchez, Federico A. ;
Saphner, Thomas J. ;
Longo, Walter L. ;
Kahl, Brad S. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (05) :379-384
[3]
Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.[J].Pierpaolo Correale;Salvatora Tindara Miano;Cinzia Remondo;Cristina Migali;Maria Saveria Rotundo;Paolo Macrì;Pierosandro Tagliaferri;Michele Caraglia;Giuseppe Gotti;Guido Francini.Cancer Biology & Therapy.2009, 6
[4]
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients.[J].Steven J. Oosterling;Anneke K. Mels;Teunis B.H. Geijtenbeek;Gerben J. van der Bij;Cornelis W. Tuk;Ronald J.C.L.M. Vuylsteke;Paul A.M. van Leeuwen;Gerrit A. Meijer;Sybren Meijer;Robert H.J. Beelen;Marjolein van Egmond.Immunobiology.2006, 6
[5]
Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer.[J].Robert Dreicer;Eric A. Klein;Paul Elson;David Peereboom;Tatiana Byzova;Edward F. Plow.Urologic Oncology: Seminars and Original Investigations.2005, 2
[6]
Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: A double-blind prospective randomized phase III study [J].
Saarilahti, K ;
Kajanti, M ;
Joensuu, T ;
Kouri, M ;
Joensuu, H .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :479-485
[7]
Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression [J].
Angel, JB ;
High, K ;
Rhame, F ;
Brand, D ;
Whitmore, JB ;
Agosti, JM ;
Gilbert, MJ ;
Deresinski, S .
AIDS, 2000, 14 (04) :387-395
[8]
Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon γ.[J].B. Schuurman;G. Heuff;R. H. J. Beelen;S. Meyer.Cancer Immunology Immunotherapy.1994, 3